Kairos Pharma, LTD. Business Finance Contracts & Agreements
4 Contracts & Agreements
- Exchange Agreements (1 contract)
- Note Agreements (3)
- Form of Investor Rights and Lock-Up Agreement for 6% Convertible Notes (Filed With SEC on September 29, 2023)
- Form of 6% Convertible Note (Filed With SEC on September 29, 2023)
- Form of Subscription Agreement for 6% Convertible Notes (Filed With SEC on September 29, 2023)
- Share Exchange Agreement between Kairos Pharma, Ltd. and Enviro Therapeutics, Inc. dated June 3, 2021 (Filed With SEC on September 29, 2023)